Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Precision needle aims to ease jaw pain in new trial

NCT ID NCT07306936

Symptom relief Sponsor: Alexandria University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a computer-guided needle technique combined with a platelet-rich plasma (PRP) injection for people with a painful jaw joint condition called temporomandibular disorder (TMD). The goal is to see if the computer-guided method improves jaw function and reduces pain better than the standard free-hand technique. Twenty-four adults who haven't improved with other treatments will be followed for three months after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
platelet-rich plasma (PRP)
What this could lead to
If successful, this could offer a more precise, less invasive treatment for jaw joint pain and clicking, potentially improving function and recovery.
What could go wrong
This is a very small, early-stage trial with only 24 participants, so results may not apply to everyone. The procedure still carries risks like infection or temporary discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

24 people

The number who actually took part.

Started

Apr 2025

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients diagnosed with internal derangement according to Wilkes stage I and II. 2. Adult patients above 18 years old. 3. Patients who would not respond to conservative treatment as a first line of treatment Exclusion Criteria: 1. Patients with Wilkes stage III, IV, V. 2. Patients suffering from any systemic diseases, platelets function disorders, fibrinogen deficiency. 3. History of mandibular fracture. 4. Lactating, pregnant or planning pregnancy women. 5. Patients receiving anticoagulation treatment or NSAIDS within 48 hours preoperatively, corticosteroid injection at treatment site within 1 month or systemic use of corticosteroids within 2 weeks.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anterior disc displacement are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

temporomandibular joint disorder temporomandibular joint dysfunction syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anterior disc displacement Internal derangement Temporomandibular disorder (TMD)

Contacts and locations

Locations

  • Outpatient clinics of Faculty of Dentistry, Alexandria University, Egypt Alexandria

    Alexandria, Alexandria Governorate, 21523, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.